![]() |
Helicos BioSciencesHelicos BioSciences is a life-science company committed to developing instruments and reagents for the high speed sequencing of single DNA and RNA molecules. High speed sequencing is a breakthrough tool for solving many important and difficult problems in biology and medicine. Helicos BioSciences’ technology will allow cancer researchers to fully and accurately characterize the cancer genome on tens of thousands of tumors, thereby elucidating the full range of molecular alterations which cause cancer, leading to a new era in cancer diagnosis and therapy. Recent NewsHelicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private PlacementHelicos Launches Open Access Web Site With Microbial Genome DataHelicos BioSciences Reports Q3 2008 Financial ResultsSteve Lombardi Named CEO of Helicos BioSciences CorporationHelicos BioSciences Announces Collaboration with Children's Oncology Group to Elucidate Genomic Signatures in Ewing's SarcomaHelicos BioSciences Announces Shipment of the World's First Single Molecule DNA SequencerHelicos BioSciences Announces First Order for the Helicos(TM) Genetic Analysis Platform |
![]() CEOSteve LombardiContact InfoOne Kendall SquareBuilding 700 Cambridge, Massachusetts 02139 Phone: 617.264.1800 Fax: 617.264.1700 Key LinksWebsiteJobs Info Highland Team Bob Higgins
Corey Mulloy
|